FDA Approves Argenx’s Vyvgart To Treat Myasthenia Gravis
The U.S. Food and Drug Administration has granted approval for argenx BV’s Vyvgart (efgartigimod) for the treatment of generalized myasthenia gravis or gMG in adults who test positive for the … Read More
